Pulmonary Fibrosis Biomarker Market

Future Market Insights

Key Insight

The pulmonary fibrosis biomarker market is projected to grow from USD 4,544.5 million in 2025 to USD 6,990.3 million by 2035, at a CAGR of 4.4%. Imaging Tests will dominate with a 50.8% market share, while idiopathic pulmonary fibrosis (ipf) will lead the indication segment with a 42.6% share.

October 24, 2025

Anurag Sharma

311 Pages

Cite this Report

Pulmonary Fibrosis Biomarker Market

https://www.futuremarketinsights.com/reports/pulmonary-fibrosis-biomarkers-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Bio-Diagnostics Ltd
BioSupply Ltd
Biogenix Inc.
Diagnostic Automation/Cortez Diagnostics Inc
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Pulmonary Fibrosis Biomarker Market

Key Players

Similar Industry Reports